ANGENIE SEELAL: Open Payments
NPI 1770059081 · MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,577 in 180 payments from 23 companies in 2025. Trend: 2023 $3,595 · 2024 $4,777 · 2025 $5,577
Food & beverage: $4,354Consulting: $1,140Education: $83
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $1,740 |
| LEO Pharma Inc. | 23 | $497 |
| Janssen Biotech, Inc. | 15 | $470 |
| Galderma Laboratories, L.P. | 15 | $369 |
| ABBVIE INC. | 15 | $350 |
| GENZYME CORPORATION | 8 | $275 |
| PFIZER INC. | 14 | $236 |
| Incyte Corporation | 10 | $210 |
| Biofrontera Inc. | 11 | $207 |
| Regeneron Healthcare Solutions, Inc. | 9 | $176 |
Products named: Bimzelx, TREMFYA, DUPIXENT, ADBRY, SKYRIZI, NEMLUVIO, OPZELURA, CIBINQO.
Industry payments across NY — which companies pay providers there.
